Performance

CGEM +63.14%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
CGEM	+3.71%	+13.33%	+63.14%	-12.68%	-52.94%	0.95	0.00%

Summary

CGEM at a glance

CGEM returned +63.14% over the past year and -12.68% a year over five years. Its worst drop in that year was -52.94%, smaller than 19% of stocks on Redstone, and its Sharpe ratio of 0.95 beats 73% of stocks on Redstone. It pays no dividends.

Ranking

How CGEM ranks

Current Drawdown

-48.89%

Rolling Volatility

105.61%

Actions

Metrics

Risk Indicators

Alpha62.84%

Beta1.56x

Sharpe0.95

Sortino1.54

Omega1.20

Calmar1.19

Martin4.53

Profile

About CGEM

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer.

Sector: Health Care
Industry: Biological Products, (no Diagnostic Substances)
Market cap: $755M
Listed: Jan 2021
Employees: 109
Headquarters: Cambridge, MA
Website: cullinantherapeutics.com

Comparisons

CGEM: Cullinan Therapeutics, Inc.

CGEM at a glance

How CGEM ranks

Current Drawdown

Rolling Volatility

About CGEM

Related comparisons